The Pitfalls of Femoropopliteal Stenting Trials

Dotter CT Judkins MP. Transluminal treatment of arteriosclerotic obstruction. description of a new technic and a preliminary report of its application. Circulation. 1964;30:654–670

Gruntzig A Hopff H. [Percutaneous recanalization after chronic arterial occlusion with a new dilator-catheter (modification of the Dotter technique) (author's transl)]. Dtsch Med Wochenschr. 1974;99:2502–2511

Anderson PL Gelijns A Moskowitz A Understanding trends in inpatient surgical volume: vascular interventions, 1980–2000. J Vasc Surg. 2004;39:1200–1208

Goodney PP Beck AW Nagle J National trends in lower extremity bypass surgery, endovascular interventions, and major amputations. J Vasc Surg. 2009;50:54–60

Rowe VL Lee W Weaver FA Patterns of treatment for peripheral arterial disease in the United States: 1996–2005. J Vasc Surg. 2009;49:910–917

Acin F de Haro J Bleda S Primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis of randomized controlled trials. J Endovasc Ther. 2012;19:585–595

Norgren L Hiatt WR Dormandy JA Inter Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45 Suppl S:S5–67

Schillinger M Sabeti S Dick P Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation. 2007;115:2745–279

Scheinert D Scheinert S Sax J Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol. 2005;45:312–315

Duda SH Pusich B Richter G Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation. 2002;106:1505–1509

Nakazawa G Finn AV Vorpahl M Incidence and predictors of drug-eluting stent fracture in human coronary artery a pathologic analysis. J Am Coll Cardiol. 2009;54:1924–1931

Ling AJ Mwipatayi P Gandhi T Stenting for carotid artery stenosis: fractures, proposed etiology and the need for surveillance. J Vasc Surg. 2008;47:1220–1226

Bosiers M Torsello G Gissler HM Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study. J Endovasc Ther. 2009;16:261–269

Laird JR Katzen BT Scheinert D RESILIENT Investigators. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv. 2010;3:267–276

Rosenschein U Topol EJ. Uncoupling clinical outcomes and coronary angiography: a review and perspective of recent trials in coronary artery disease. Am Heart J. 1996;132:910–920

Cacoub PP Bhatt DL Steg PG Patients with peripheral arterial disease in the CHARISMA trial. Eur Heart J. 2009;30:192–201

Dorffler-Melly J Koopman MM Prins MH Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment. Cochrane Database Syst Rev. 2005(1):CD002071

Tepe G Bantleon R Brechtel K Management of peripheral arterial interventions with mono or dual antiplatelet therapy-the MIRROR study: a randomised and double-blinded clinical trial. Eur Radiol. 2012 May 10. [Epub ahead of print]